Literature DB >> 11429162

Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.

S A Beresford1, M A Davies, G E Gallick, N J Donato.   

Abstract

Alterations in phosphatidylinositol 3'-kinase (PI3'-kinase) and Akt activation frequently occur in prostate cancer and may disrupt apoptotic induction by such cytokines as tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand (TRAIL). To examine the role of PI3' phosphorylation in the cellular response to cytokines, two prostate cancer cell lines with constitutively activated PI3'-kinase cascades (LNCaP and PC-3) were examined for direct sensitivity to cytokines. TNF or TRAIL alone failed to activate apoptosis in either LNCaP or PC-3 cells, and drug-mediated inhibition of the PI3k/Akt cascade caused only minimal activation of apoptosis in either cell line. Suppression of PI3'-kinase/Akt signaling markedly enhanced the apoptotic activity of both TNF and TRAIL in LNCaP cells but not in PC-3 cells. Adenovirus-mediated PTEN/MMAC1 expression in LNCaP cells reduced Akt activation, activated apoptosis, and sensitized cells to TNF but not to TRAIL. Together, these results suggest that PI3'-kinase signaling inhibits both TNF-mediated and TRAIL-mediated apoptosis but may represent one of several apoptotic resistance mechanisms that inhibit cytokine-mediated killing of prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429162     DOI: 10.1089/107999001300177501

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  5 in total

Review 1.  Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.

Authors:  Todd M Morgan; Theodore D Koreckij; Eva Corey
Journal:  Curr Cancer Drug Targets       Date:  2009-03       Impact factor: 3.428

2.  Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms.

Authors:  Diping Wang; Ji Lu; Donald J Tindall
Journal:  Cancer Lett       Date:  2013-02-09       Impact factor: 8.679

3.  Cytokine effects on cell viability and death of prostate carcinoma cells.

Authors:  Georgios Chondrogiannis; Michalis Kastamoulas; Panagiotis Kanavaros; Georgios Vartholomatos; Maria Bai; Dimitrios Baltogiannis; Nikolaos Sofikitis; Dimitrios Arvanitis; Vasiliki Galani
Journal:  Biomed Res Int       Date:  2014-05-29       Impact factor: 3.411

4.  Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones.

Authors:  Maja Marklund; Niklas Schultz; Stefanie Friedrich; Emelie Berglund; Firas Tarish; Anna Tanoglidi; Yao Liu; Ludvig Bergenstråhle; Andrew Erickson; Thomas Helleday; Alastair D Lamb; Erik Sonnhammer; Joakim Lundeberg
Journal:  Nat Commun       Date:  2022-09-17       Impact factor: 17.694

Review 5.  Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer.

Authors:  Delisha A Stewart; Carlton R Cooper; Robert A Sikes
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.